190 related articles for article (PubMed ID: 15595394)
21. Pharmaceutical formularies: the right formula for cost and utilization?
Austin B
Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
[No Abstract] [Full Text] [Related]
22. Managed care pharmacy 101: learning from the students.
Penna P
Manag Care Interface; 2005 Apr; 18(4):28, 31. PubMed ID: 15889760
[No Abstract] [Full Text] [Related]
23. The use of pharmacoeconomic data in managed care: closing the credibility gap.
Lewis BE
Manag Care Interface; 1997 Nov; 10(11):99-103. PubMed ID: 10174761
[TBL] [Abstract][Full Text] [Related]
24. Cost not the primary factor driving drug coverage.
Capitation Rates Data; 2000 May; 5(5):51-3. PubMed ID: 11066970
[No Abstract] [Full Text] [Related]
25. ED drugs covered, but managed care unmoved.
Manag Care; 2005 Mar; 14(3):64. PubMed ID: 15825613
[No Abstract] [Full Text] [Related]
26. The FDA's regulation of pharmaceutical communications in the context of managed care: a suggested approach.
Kuhlik BN
Food Drug Law J; 1995; 50(1):23-48. PubMed ID: 10342984
[No Abstract] [Full Text] [Related]
27. The formulary files. ARB costs run high in Medicare part D.
Manag Care; 2007 Aug; 16(8):48. PubMed ID: 17886540
[No Abstract] [Full Text] [Related]
28. Ethical principles for psychiatric administrators: the challenge of formularies.
Moffic HS
Psychiatr Q; 2006; 77(4):319-27. PubMed ID: 16927163
[TBL] [Abstract][Full Text] [Related]
29. The ripple effects of a restrictive Medicaid formulary.
Grabowski H
Am J Manag Care; 2003 Oct; 9(10):648-9. PubMed ID: 14572174
[No Abstract] [Full Text] [Related]
30. Grassley, CMS: USP classes won't get formulary a free pass.
Med Health; 2004 Oct; 58(36):3-4. PubMed ID: 15499734
[No Abstract] [Full Text] [Related]
31. Reinventing the PBM (pharmacy benefit manager).
Marcille JA; Wynn P
Manag Care; 1997 Apr; 6(4):64-6, 75-8. PubMed ID: 10167003
[No Abstract] [Full Text] [Related]
32. Do P&T committees have enough power? Plans and PBMs are divided about sharing drug prices with clinicians. Is it better to have an administrative committee determine the formulary?
Cross M
Manag Care; 2007 Apr; 16(4):39-42. PubMed ID: 17491288
[No Abstract] [Full Text] [Related]
33. MMA formulary design requires health plans to control costs.
Sipkoff M
Manag Care; 2005 Jun; 14(6):18, 20. PubMed ID: 16044883
[No Abstract] [Full Text] [Related]
34. Medicare program: Medicare Advantage and prescription drug programs MIPPA drug formulary & protected classes policies. Interim final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2009 Jan; 74(11):2881-8. PubMed ID: 19385109
[TBL] [Abstract][Full Text] [Related]
35. Bad tiered formulary designs yield poor outcomes, high cost.
Sipkoff M
Manag Care; 2004 Aug; 13(8):27, 31-2, 34-5. PubMed ID: 15457893
[No Abstract] [Full Text] [Related]
36. The Academy of Managed Care Pharmacy's format for formulary submission.
Penna P
Manag Care Interface; 2001 Jun; 14(6):61-2. PubMed ID: 11432152
[No Abstract] [Full Text] [Related]
37. Access to cancer drugs in Medicare Part D: formulary placement and beneficiary cost sharing in 2006.
Bowman J; Rousseau A; Silk D; Harrison C
Health Aff (Millwood); 2006; 25(5):1240-8. PubMed ID: 16966719
[TBL] [Abstract][Full Text] [Related]
38. Formulary submission process catches on ... slowly.
Cross M
Manag Care; 2002 Nov; 11(11):32-6. PubMed ID: 12491856
[No Abstract] [Full Text] [Related]
39. A look ahead for managed care pharmacy in 2006.
Giaquinta D
Manag Care Interface; 2006 Feb; 19(2):39-40. PubMed ID: 16529079
[No Abstract] [Full Text] [Related]
40. Pharmaceutical benefit management: an alternative approach.
Danzon PM
Health Aff (Millwood); 2000; 19(2):24-5. PubMed ID: 10718019
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
